87650 Infectious agent detection by nucleic acid (DNA or RNA); Streptococcus, group A, direct probe technique

Name of the Procedure:

Infectious Agent Detection by Nucleic Acid (DNA or RNA); Streptococcus, Group A, Direct Probe Technique

Summary

The Streptococcus group A detection by nucleic acid involves using a direct probe technique to identify the presence of Group A Streptococcus bacteria in a patient's sample. This method identifies bacterial DNA or RNA, ensuring accurate diagnoses.

Purpose

This procedure is used to diagnose infections caused by Group A Streptococcus, which can lead to illnesses such as strep throat, scarlet fever, and skin infections. The goal is to swiftly and accurately confirm the presence of the bacteria to guide appropriate treatment and prevent complications.

Indications

• Symptoms of a throat infection such as sore throat, fever, and swollen lymph nodes.
• Rash associated with scarlet fever.
• Skin infections such as impetigo.

• Recurrent or persistent symptoms despite treatment.

  Preparation

• No special preparation is generally required.
• Patients should inform their healthcare provider of any recent antibiotic use, as this may affect the results.

Procedure Description

1. A swab is collected from the patient, typically from the throat.
2. The sample is processed to extract bacterial DNA or RNA.
3. Specific probes are used to detect Group A Streptococcus nucleic acid sequences.
4. Results are analyzed to determine the presence of the bacterial genetic material.
   • The process involves advanced laboratory equipment and technology.
   • Anesthesia or sedation is usually not necessary.

Duration

The actual sample collection takes a few minutes. Results can often be available within several hours to a day, depending on the laboratory processing time.

Setting

The sample is usually collected in a primary care office, outpatient clinic, or hospital. The analysis is conducted in a specialized laboratory.

Personnel

• Primary care physician or nurse for sample collection.
• Laboratory professionals for the processing and analysis of the sample.

Risks and Complications

• Minimal risks associated with collecting the swab sample, such as slight discomfort or gagging.
• Rarely, false negatives or positives can occur, requiring further testing or clinical correlation.

Benefits

• Rapid and accurate identification of Group A Streptococcus.
• Appropriate and timely treatment can be started, reducing symptoms and preventing complications.
• Helps avoid unnecessary antibiotic use if results are negative.

Recovery

• No recovery time needed from the procedure itself.
• Patients should follow their physician's instructions regarding follow-up, especially if treatment is initiated based on the results.

Alternatives

• Traditional throat culture, which has a longer turnaround time but is also accurate.
• Rapid antigen tests, which are faster but less sensitive compared to nucleic acid detection.

Patient Experience

• The patient may experience brief discomfort during the swab collection.
• Anxiety related to awaiting results can be common.
• Pain management is not typically required.

Overall, the process is generally quick, non-invasive, and highly effective in diagnosing Group A Streptococcus infections.